| Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis E Chouri, NH Servaas, CPJ Bekker, AJ Affandi, M Cossu, MR Hillen, ... Journal of Autoimmunity 89, 162-170, 2018 | 77 | 2018 |
| Leflunomide–hydroxychloroquine combination therapy in patients with primary Sjögren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial EHM van der Heijden, SLM Blokland, MR Hillen, APP Lopes, ... The Lancet Rheumatology 2 (5), e260-e269, 2020 | 60 | 2020 |
| Plasmacytoid DCs from patients with Sjögren's syndrome are transcriptionally primed for enhanced pro-inflammatory cytokine production MR Hillen, A Pandit, SLM Blokland, SAY Hartgring, CPJ Bekker, ... Frontiers in immunology 10, 2096, 2019 | 59 | 2019 |
| Elevated CCL25 and CCR9‐Expressing T Helper Cells in Salivary Glands of Primary Sjögren's Syndrome Patients: Potential New Axis in Lymphoid Neogenesis SLM Blokland, MR Hillen, AA Kruize, S Meller, B Homey, GM Smithson, ... Arthritis & Rheumatology 69 (10), 2038-2051, 2017 | 53* | 2017 |
| Dendritic cells, T-cells and epithelial cells: a crucial interplay in immunopathology of primary Sjögren's syndrome MR Hillen, FA Ververs, AA Kruize, JA Van Roon Expert review of clinical immunology 10 (4), 521-531, 2014 | 47 | 2014 |
| Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndrome M van der Kroef, LL van den Hoogen, JS Mertens, SLM Blokland, ... European journal of immunology 50 (1), 119-129, 2020 | 44 | 2020 |
| Salivary gland pathology in Sjögren's syndrome J Campos, MR Hillen, F Barone Rheumatic Disease Clinics 42 (3), 473-483, 2016 | 38 | 2016 |
| High soluble IL-7 receptor expression in Sjögren's syndrome identifies patients with increased immunopathology and dryness MR Hillen, SLM Blokland, AP Risselada, A Bikker, BR Lauwerys, ... Annals of the rheumatic diseases 75 (9), 1735-1736, 2016 | 25 | 2016 |
| Implication of miR-126 and miR-139-5p in plasmacytoid dendritic cell dysregulation in systemic sclerosis E Chouri, M Wang, MR Hillen, C Angiolilli, SC Silva-Cardoso, ... Journal of clinical medicine 10 (3), 491, 2021 | 24 | 2021 |
| Epigenetically quantified immune cells in salivary glands of Sjögren’s syndrome patients: a novel tool that detects robust correlations of T follicular helper cells with … SLM Blokland, FM van Vliet-Moret, MR Hillen, A Pandit, R Goldschmeding, ... Rheumatology 59 (2), 335-343, 2020 | 21 | 2020 |
| Dysregulated miRNome of plasmacytoid dendritic cells from patients with Sjögren’s syndrome is associated with processes at the centre of their function MR Hillen, E Chouri, M Wang, SLM Blokland, SAY Hartgring, ... Rheumatology 58 (12), 2305-2314, 2019 | 20 | 2019 |
| Salivary gland secretome: a novel tool towards molecular stratification of patients with primary Sjögren’s syndrome and non-autoimmune sicca SLM Blokland, MR Hillen, FM van Vliet-Moret, A Bikker, W de Jager, ... RMD open 5 (1), e000772, 2019 | 20 | 2019 |
| Increased mTORC1 activation in salivary gland B cells and T cells from patients with Sjögren’s syndrome: mTOR inhibition as a novel therapeutic strategy to halt immunopathology? SLM Blokland, MR Hillen, CGK Wichers, M Zimmermann, AA Kruize, ... RMD open 5 (1), e000701, 2019 | 20 | 2019 |
| Clinical efficacy of leflunomide/hydroxychloroquine combination therapy in patients with primary Sjögren’s syndrome: results of a placebo-controlled double-blind randomized … T Radstake, E Van Der Heijden, F Moret, MR Hillen, AP Lopes, ... Arthritis Rheumatol 70 (10), 2018 | 20 | 2018 |
| The transcriptomic profile of monocytes from patients with Sjögren’s syndrome is associated with inflammatory parameters and is mimicked by circulating mediators AP Lopes, CPJ Bekker, MR Hillen, SLM Blokland, AC Hinrichs, A Pandit, ... Frontiers in Immunology 12, 701656, 2021 | 17 | 2021 |
| MicroRNA-130a contributes to type-2 classical DC-activation in Sjögren's syndrome by targeting mitogen-and stress-activated protein kinase-1 AP Lopes, JAG Van Roon, SLM Blokland, M Wang, E Chouri, ... Frontiers in Immunology 10, 1335, 2019 | 16* | 2019 |
| Decreased expression of thymic stromal lymphopoietin in salivary glands of patients with primary Sjögren’s syndrome is associated with increased disease activity MR Hillen, AA Kruize, A Bikker, M Wenting-van Wijk, TRDJ Radstake, ... Modern Rheumatology 26 (1), 105-109, 2016 | 15 | 2016 |
| Thymic stromal lymphopoietin as a novel mediator amplifying immunopathology in rheumatic disease MR Hillen, TRDJ Radstake, CE Hack, JAG van Roon Rheumatology 54 (10), 1771-1779, 2015 | 13 | 2015 |
| Targeting CD1c-expressing classical dendritic cells to prevent thymus and activation-regulated chemokine (TARC)-mediated T-cell chemotaxis in rheumatoid arthritis MR Hillen, FM Moret, KMG van der Wurff-Jacobs, T Radstake, CE Hack, ... Scandinavian Journal of Rheumatology 46 (1), 11-16, 2017 | 12* | 2017 |
| Towards standardisation of histopathological assessments of germinal centres and lymphoid structures in primary Sjögren's syndrome MR Hillen, F Barone, TRDJ Radstake, JAG Van Roon Annals of the Rheumatic Diseases 75 (6), e31-e31, 2016 | 12 | 2016 |
Timothy RadstakeHead Early Immunology Discovery Research, AbbvieVerified email at abbvie.com
